Financhill
Sell
1

NIVF Quote, Financials, Valuation and Earnings

Last price:
$0.45
Seasonality move :
0%
Day range:
$0.42 - $0.54
52-week range:
$0.42 - $65.60
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
0.86x
Volume:
2.7M
Avg. volume:
4.4M
1-year change:
-98.49%
Market cap:
$770.3K
Revenue:
$5.1M
EPS (TTM):
--

Analysts' Opinion

  • Consensus Rating
    No consensus rating exists at this time due to lack of analyst coverage.
  • Price Target Downside
    No price target exists because of limited analyst coverage.
  • Price Target Upside
    Similarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.

Fair Value

  • According to the consensus of 0 analysts, NewGenIvf Group has -- downside to fair value with a price target of -- per share.

NIVF vs. S&P 500

  • Over the past 5 trading days, NewGenIvf Group has underperformed the S&P 500 by -46.94% suggesting its relative strength compared to the major market average is weak at this time.

Share Buyback

  • NewGenIvf Group does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • NewGenIvf Group has grown year-over-year revenues for 0 quarters straight. In the most recent quarter NewGenIvf Group reported revenues of --.

Earnings Growth

  • NewGenIvf Group has grown year-over-year earnings for 0 quarters straight. In the most recent quarter NewGenIvf Group reported earnings per share of --.
Enterprise value:
226.1K
EV / Invested capital:
--
Price / LTM sales:
--
EV / EBIT:
--
EV / Revenue:
--
PEG ratio (5yr expected):
--
EV / Free cash flow:
--
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
--
Return On Assets:
--
Net Income Margin (TTM):
--
Return On Equity:
--
Return On Invested Capital:
--
Operating Margin:
--
Trailing 12 Months Fiscal Quarters
Period Ending 2023-04-06 2024-04-06 2024-04-06
Income Statement
Revenue -- -- -- -- --
Gross Profit -- -- -- -- --
Operating Income -- -- -- -- --
EBITDA -- -- -- -- --
Diluted EPS -- -- -- -- --
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Balance Sheet
Current Assets -- -- -- $2.4M $1.2M
Total Assets -- -- -- $2.9M $1.6M
Current Liabilities -- -- -- $2.6M $1.1M
Total Liabilities -- -- -- $2.8M $1.2M
Total Equity -- -- -- $100.7K $406K
Total Debt -- -- -- -- --
Trailing 12 Months Fiscal Quarters
Period Ending 2023-04-06 2024-04-06 2024-04-06
Cash Flow Statement
Cash Flow Operations -- -- -- -- --
Cash From Investing -- -- -- -- --
Cash From Financing -- -- -- -- --
Free Cash Flow -- -- -- -- --
NIVF
Sector
Market Cap
$770.3K
$33.6M
Price % of 52-Week High
0.69%
40.87%
Dividend Yield
0%
0%
Shareholder Yield
--
-0.91%
1-Year Price Total Return
-98.49%
-46.67%
Beta (5-Year)
--
0.744
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years

Technicals

8-day SMA
Sell
Level $0.71
200-day SMA
Sell
Level $11.48
Bollinger Bands (100)
Sell
Level 1.53 - 9.37
Chaikin Money Flow
Sell
Level -144.4M
20-day SMA
Sell
Level $0.91
Relative Strength Index (RSI14)
Sell
Level 25.43
ADX Line
Buy
Level 16.56
Williams %R
Buy
Level -96.394
50-day SMA
Sell
Level $2.14
MACD (12, 26)
Sell
Level -0.48
25-day Aroon Oscillator
Sell
Level -96
On Balance Volume
Sell
Level -78.4M

Financial Scores

--
Altman Z-Score (Annual)
Level (--)
Buy
CA Score (Annual)
Level (-0.0956)
--
Beneish M-Score (Annual)
Level (--)
--
Momentum Score
Level (--)
Sell
Ohlson Score
Level (5.4929)
Buy
Piotroski F Score (Annual)
Level (4)
--
Quality Ratio Score
Level (--)
--
Fundamental Score
Level (--)

Revenue Forecast

Earnings per Share Forecast

Company Profile

NewGenIvf Group Ltd is a company engaged in providing assisted reproductive services in Asia Pacific with a focus on providing fertility treatments to fulfil the dreams of building families, NewGenIvf mainly offers two services, namely first which is a  in-vitro fertilization (IVF) treatment service, comprising traditional IVF and egg donation; and  surrogacy and ancillary caring services.

Stock Forecast FAQ

In the current month, NIVF has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The NIVF average analyst price target in the past 3 months is --.

  • Where Will NewGenIvf Group Stock Be In 1 Year?

    According to analysts, the consensus estimate is that NewGenIvf Group share price will drop to -- per share over the next 12 months.

  • What Do Analysts Say About NewGenIvf Group?

    Analysts are divided on their view about NewGenIvf Group share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that NewGenIvf Group is a Sell and believe this share price will rise from its current level to --.

  • What Is NewGenIvf Group's Price Target?

    The price target for NewGenIvf Group over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.

  • Is NIVF A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for NewGenIvf Group is a --. 0 of 0 analysts rate the stock a -- at this time.

  • How Can I Buy Shares Of NIVF?

    You can purchase shares of NewGenIvf Group via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase NewGenIvf Group shares.

  • What Is The NewGenIvf Group Share Price Today?

    NewGenIvf Group was last trading at $0.45 per share. This represents the most recent stock quote for NewGenIvf Group. Yesterday, NewGenIvf Group closed at $0.45 per share.

  • How To Buy NewGenIvf Group Stock Online?

    In order to purchase NewGenIvf Group stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is ROOT Stock the Next Big Thing?
Is ROOT Stock the Next Big Thing?

Root Holdings (NASDAQ:ROOT) is the parent company of Root Insurance,…

Is Okta a Good Stock to Buy?
Is Okta a Good Stock to Buy?

Okta (NASDAQ:OKTA) is used by some of the largest firms…

Is Fidelity High Dividend ETF a Good Investment Now?
Is Fidelity High Dividend ETF a Good Investment Now?

Fidelity’s High Dividend ETF (FDVV) is a fund that offers…

Stock Ideas

Sell
37
Is AAPL Stock a Buy?

Market Cap: $2.8T
P/E Ratio: 31x

Sell
37
Is MSFT Stock a Buy?

Market Cap: $2.7T
P/E Ratio: 30x

Sell
31
Is NVDA Stock a Buy?

Market Cap: $2.3T
P/E Ratio: 32x

Alerts

Sell
45
RGC alert for Apr 5

Regencell Bioscience Holdings [RGC] is up 32.59% over the past day.

Sell
25
GDXU alert for Apr 5

MicroSectors Gold Miners 3X Leveraged ETN [GDXU] is down 27.33% over the past day.

Buy
76
SOXS alert for Apr 5

Direxion Daily Semiconductor Bear 3X Shares [SOXS] is up 23.96% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock